StockData
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31

VACCINEX, INC.

Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026

Market cap
$3.22M
P/E (TTM)
–
Dividend yield
–

VACCINEX, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Vaccinex does not break out revenue by segment, region or product in the tagged data of its filings for this period type.